These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 520395

  • 1. The pharmacokinetics of misonidazole in the dog.
    White RA, Workman P, Freedman LS, Owen LN, Bleehen NM.
    Eur J Cancer (1965); 1979 Oct; 15(10):1233-42. PubMed ID: 520395
    [No Abstract] [Full Text] [Related]

  • 2. The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole.
    White RA, Workman P, Brown JM.
    Radiat Res; 1980 Dec; 84(3):542-61. PubMed ID: 6450431
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic considerations of misonidazole in therapeutics.
    Matheson I, Plowman PN, Johnston A.
    Hum Toxicol; 1984 Feb; 3(1):29-36. PubMed ID: 6698564
    [Abstract] [Full Text] [Related]

  • 4. Kinetics of misonidazole enantiomers.
    Williams KM.
    Clin Pharmacol Ther; 1984 Dec; 36(6):817-23. PubMed ID: 6499361
    [Abstract] [Full Text] [Related]

  • 5. Misonidazole dose and tumor level relationships. Effects of individual variation in rate of misonidazole metabolism and absorption from the gastrointestinal tract.
    Strong JM, Schwade JG, Gangji D, Shoemaker DD, Upton DK.
    Cancer Clin Trials; 1981 Dec; 4(1):41-6. PubMed ID: 7214661
    [No Abstract] [Full Text] [Related]

  • 6. Phenytoin sodium-induced alterations in the pharmacokinetics of misonidazole in the dog.
    White RA, Workman P.
    Cancer Treat Rep; 1980 Dec; 64(2-3):360-1. PubMed ID: 7190871
    [No Abstract] [Full Text] [Related]

  • 7. The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice.
    Chin JB, Rauth AM.
    Radiat Res; 1981 May; 86(2):341-57. PubMed ID: 7232696
    [No Abstract] [Full Text] [Related]

  • 8. Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
    Moore JL, Paterson IC, Newman H, Venables S.
    Br J Cancer; 1981 Oct; 44(4):592-6. PubMed ID: 7295516
    [No Abstract] [Full Text] [Related]

  • 9. Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.
    Workman P.
    Cancer Chemother Pharmacol; 1980 Oct; 5(1):27-37. PubMed ID: 7460192
    [Abstract] [Full Text] [Related]

  • 10. Misonidazole blood and cerebrospinal fluid kinetics in monkeys following intravenous and intrathecal administration.
    Gangji D, Poplack DG, Schwade J, Wood JH, Strong JM.
    Eur J Cancer (1965); 1981 Jan; 17(1):29-34. PubMed ID: 6894901
    [No Abstract] [Full Text] [Related]

  • 11. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
    Meering PG, Gonzalez DG, Maes RA, van Peperzeel HA.
    Hum Toxicol; 1985 Jul; 4(4):425-34. PubMed ID: 4018823
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the bioavailability of misonidazole (NSC#261037) in capsule and tablet form and pharmacologic effects of daily dosage.
    VanRaalte G, Phillips TL, Wasserman TH.
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):279-82. PubMed ID: 7085383
    [Abstract] [Full Text] [Related]

  • 13. The penetration of misonidazole into spontaneous canine tumours.
    White RA, Workman P, Owen LN, Bleehen NM.
    Br J Cancer; 1979 Aug; 40(2):284-94. PubMed ID: 289406
    [Abstract] [Full Text] [Related]

  • 14. Phenytoin-misonidazole: possible metabolic interaction.
    Gangji D, Schwade JG, Strong JM.
    Cancer Treat Rep; 1980 Jan; 64(1):155-6. PubMed ID: 7379050
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A drug for improved radiosensitization in radiotherapy.
    Dische S, Fowler JF, Saunders MI, Stratford MR, Anderson P, Minchinton AI, Lee ME.
    Br J Cancer; 1980 Jul; 42(1):153-5. PubMed ID: 7426325
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.